New Technology– category –
-
Carbon Nanotube Nanocomposite: Enzyme-free glucose sensor specs
CRC Press (Taylor & Francis Group) Overview A novel enzyme-free glucose sensor leveraging carbon nanotube and cobalt oxide nanocomposites has been developed, achieving exceptionally high sensitivity of 18.47 mA/mM/cm² for glucose detecti... -
Wearable Biosensors Predict Imminent Aggressive Behavior in Autistic Youth with 80% Accuracy, Three Minutes in Advance
Artemis ABA (citing JAMA Network Open) USA Overview A study involving 70 psychiatric inpatient youths with autism demonstrated that wrist-worn biosensors could predict aggressive behavior an average of 3 minutes before its onset, achievi... -
Continuous Glucose Monitoring Patterns Identify Cardiometabolic Risk in Non-Diabetic Adults, Diabetes Care Study Reports
Drugs.com USA Overview A study published in *Diabetes Care* reveals that continuous glucose monitor (CGM) patterns are linked to cardiometabolic risk in adults without diabetes. Analyzing data from 1,356 participants using blinded Dexcom... -
AI-Enhanced Photonic Biosensor Achieves High-Precision Glioblastoma Tissue Detection in Ultra-Compact 76μm² Footprint
AZoSensors International Overview Numerical simulations have demonstrated the development of an ultra-compact photonic biosensor integrated with AI, capable of distinguishing glioblastoma (GBM) tissue from surrounding brain tissue with h... -
SKKU Develops Stretchable Sensor Converting Underwater Ultrasound to Neural Signals, Mimicking Dolphin Sonar
Sungkyunkwan University (SKKU) External Affairs Division (PR team) South Korea Overview A research team at Sungkyunkwan University (SKKU) has successfully developed a novel stretchable sensor capable of converting underwater ultrasound d... -
FDA Updates De Novo Classification List, Accelerating Market Entry for Biosensors and Other Novel Low-to-Moderate Risk Devices
FDA USA Overview The FDA has updated its De Novo classification list, a critical pathway for novel medical devices of low to moderate risk, including biosensors. This update reflects ongoing regulatory clearances for innovative technolog... -
Graphene’s Extreme Strength and Conductivity Poised to Revolutionize Biomedical Technologies, Enhancing Biosensors and Drug Delivery
grapheneuses.org Overview Graphene's exceptional mechanical strength (over 100 times stronger than steel), high electrical and thermal conductivity, optical transparency, and impermeability make it a promising material for biomedical tec... -
Roche Diagnostics Deploys First Large-Scale DNA Sequencer in Spain, Accelerating Human Genome Analysis to 4 Hours for Cancer and Rare Disease Research
PR Newswire Spain Overview Roche Diagnostics has installed its first large-scale DNA sequencer in Spain at the National Centre for Genomic Analysis (CNAG) in Barcelona. This cutting-edge technology can analyze a complete human genome in ... -
Digital Biomarkers: AI wearable sensors for chemotherapy detection
Frontiers Unknown Overview This perspective article explores how wearable sensors and digital biomarkers can enable subclinical detection of chemotherapy-induced peripheral neuropathy (CIPN). It proposes a framework for prediction and di... -
Abbott Libre DUO 10 Day: FDA approval for glucose/ketone monitoring
Prime Therapeutics - Portal USA Overview Abbott Diabetes Care has received FDA approval for its "Libre DUO 10 Day" continuous dual glucose-ketone monitoring system for diabetic patients aged two and older. This device marks the first wea...
